Manejo diagnóstico-terapéutico de las lesiones mamarias atípicas

Resumen

Las lesiones mamarias se dividen histológicamente en dos grandes grupos, malignas y benignas. Las lesiones malignas pueden ser de origen ductal o lobulillar, siendo el carcinoma ductal infiltrante la neoplasia invasiva más frecuente. Las lesiones benignas se clasifican en no proliferativas, proliferativas sin atipias y proliferativas con atipias. Dentro de los dos últimos grupos se encuentran entidades que conllevan un alto riesgo de desarrollar carcinoma de mama, como pueden ser la hiperplasia ductal atípica, la cicatriz radial o la neoplasia lobular. Revisamos en qué consisten dichas entidades y cuáles son sus características principales en imagen, fundamentalmente en mamografía y ecografía. Si tras realizar una biopsia se obtiene uno de esos diagnósticos histológicos, es importante analizar las características imagenológicas y el tipo de procedimiento realizado (número de cilindros obtenidos, calibre de aguja...), para realizar un adecuado manejo posterior. En algunos casos la actitud a seguir será la extirpación quirúrgica completa de la lesión, mientras que en otros se podrá realizar una extirpación percutánea (mediante biopsia con aguja de vacio), o incluso seguimiento estricto por imagen. Mediante diferentes casos mostraremos nuestra experiencia y analizaremos la literatura vigente para recordar esas entidades y llegar a un consenso adecuado sobre el manejo de las mismas.

Abstract

Breast lesions are divided histologically into two large groups, malignant and benign. Malignant lesions may be of ductal or lobular origin, with infiltrating ductal carcinoma being the most frequent invasive neoplasm. Benign breast lesions are classified as proliferative, proliferative without atypia and proliferative with atypia. Within the last two classifications are entities that carry a high risk of developing breast carcinoma, such as atypical ductal hyperplasia, radial scar or lobular neoplasia. We review what these entities consist of and what are their fundamental characteristics in image, fundamentally in mammography and ultrasound. When we perform one of these histological diagnoses after a biopsy, it is important to analyze the radiological characteristics and the type of procedure performed (number of cylinders, needle gauge ...) to perform an appropriate posterior management. In some cases the attitude to be followed will be the complete surgical removal of the lesion, while in others a percutaneous excision (through vacuum needle biopsy) or even strict image follow-up may be performed. Through different cases we will show our experience and analyze current literature to remember these entities and reach an adequate management consensus.

Palabras clave

hiperplasia ductal atípica - cicatriz radial - neoplasia lobular - tumor phyllodes - linfoma mamario

Keywords

atypical duct hiperplasia - radial scar - lobular neoplasia - phyllodes tumor - breast lymphoma

• Bibliografía

• 1 Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 2003; 27 (06) 836-841
• 2 London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992; 267 (07) 941-944
• 3 Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312 (03) 146-151
• 4 Hartmann LC, Sellers TA, Frost MH. , et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005; 353 (03) 229-237
• 5 Schnitt SJ, Collins LC. Pathology of benign breast disorders. In: Breast diseases, Harris JR. , et al (Eds), Lippincott: 2010. . p.69
• 6 Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist 2006; 11 (05) 435-449
• 7 Degnim AC, Visscher DW, Berman HK. , et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 2007; 25 (19) 2671-2677
• 8 Wen X, Cheng W. Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors. Ann Surg Oncol 2013; 20 (01) 94-101
• 9 Lewis JT, Hartmann LC, Vierkant RA. , et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 2006; 30 (06) 665-672
• 10 Valdes EK, Feldman SM, Boolbol SK. Papillary lesions: a review of the literature. Ann Surg Oncol 2007; 14 (03) 1009-1013
• 11 Mercado CL, Hamele-Bena D, Oken SM, Singer CI, Cangiarella J. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 2006; 238 (03) 801-808
• 12 Sydnor MK, Wilson JD, Hijaz TA, Massey HD, Shaw de Paredes ES. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology 2007; 242 (01) 58-62
• 13 Manfrin E, Remo A, Falsirollo F, Reghellin D, Bonetti F. Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases. Breast Cancer Res Treat 2008; 107 (03) 371-377
• 14 Schnitt SJ. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia--classification, pathologic features and clinical significance. Breast Cancer Res 2003; 5 (05) 263-268
• 15 Wagoner MJ, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol 2009; 131 (01) 112-121
• 16 Ko E, Han W, Lee JW. , et al. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy. Breast Cancer Res Treat 2008; 112 (01) 189-195
• 17 Menes TS, Rosenberg R, Balch S, Jaffer S, Kerlikowske K, Miglioretti DL. Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium. Am J Surg 2014; 207 (01) 24-31
• 18 Visvanathan K, Chlebowski RT, Hurley P. , et al; American Society of Clinical Oncology. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol 2009; 27 (19) 3235-3258
• 19 Morrow M, Schnitt SJ. Lobular carcinoma in situ. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Hellman S. (Eds), Philadelphia: Lippincott-Raven; 1995. . p.369
• 20 Wurdinger S, Herzog AB, Fischer DR. , et al. Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol 2005; 185 (05) 1317-1321
• 21 A Thomas Stavros. Ecografía de mama. Madrid: Marban; 2007
• 22 Brown AC, Audisio RA, Regitnig P. Granular cell tumour of the breast. Surg Oncol 2011; 20 (02) 97-105
• 23 Meyer JE, Kopans DB, Long JC. Mammographic appearance of malignant lymphoma of the breast. Radiology 1980; 135 (03) 623-626
• 24 Lyons JA, Myles J, Pohlman B, Macklis RM, Crowe J, Crownover RL. Treatment of prognosis of primary breast lymphoma: a review of 13 cases. Am J Clin Oncol 2000; 23 (04) 334-336
• 25 van der Veldt AA, Kleijn SA, Nanayakkara PW. Silicone breast implants and anaplastic large T-cell lymphoma. JAMA 2009; 301 (12) 1227 , author reply 1227